Friday, January 21, 2022

MonoClonal..

 




The use of some monoclonal antibody treatments against COVID is now being discouraged, and updated guidelines from the NIH COVID Treatment Panel say Regeneron and Eli Lilly's treatments have been shown to fail against omicron.

Officials said Sotrovimab is the only monoclonal antibody treatment for COVID that has so far been shown to hold up against omicron.

Hospitals, drug companies and Biden administration officials are racing to address one of the Omicron variant’s biggest threats: Two of the three monoclonal antibody treatments that doctors have depended on to keep Covid-19 patients from becoming seriously ill do not appear to thwart the latest version of the coronavirus.

The one such treatment that is still likely to work against Omicron is now so scarce that many doctors and hospitals have already run through their supplies. 

It is a new era today. When the Biden's administration thought they got the hang of it with 850,000 Death from Covid, a new threat to Biden's Ego appears. With that the lies that was rerouted repeatedly is clearing out.

Just a thought.

No comments:

Post a Comment